Advances in Therapeutics against Eukaryotic Pathogens
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 July 2024 | Viewed by 3406
Special Issue Editor
Special Issue Information
Dear Colleagues,
Eukaryotic pathogens are responsible for devastating diseases across the world, and, coupled with that, physicians are limited regarding their use of administering efficacious, tolerable, and non-toxic therapeutic options to patients in need. Moreover, given the lack of vaccinations for such diseases, or even the disposition of drug resistance, humankind heavily depends on anti-parasitic drugs. It is often observed that chemical therapeutics with biological activity against one pathogen may also be effective against another, or others. Thus, this Special Issue aims to identify recent advances from therapeutic drug compounds against eukaryotic microorganisms that cause human disease, which will be showcased and discussed. Submissions of experimental or simulated medicinal chemistry research that focus on the development of either known therapeutics and/or the discovery of novel compounds will be of high priority. Since Int. J. Mol. Sci. is dedicated to chemistry and biology at the molecular level, pure clinical studies will not be considered, but clinical submissions with biomolecular experiments are certainly welcomed.
Dr. Edward L. D'Antonio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- parasitology
- pathogen
- drug-target
- NTD
- cryptosporidia
- Giardia
- helminths
- Leishmania
- Naegleria
- Plasmodium
- Schistosoma
- Toxoplasma
- Trichomonas
- Trypanosoma